Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare Biotechnology
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd
Bullboard Posts
User Avatar Image
(1)
•••
Comment by den1731on Dec 10, 2018 12:04pm
83 Views
Post# 29091975

RE:RE:Even if you're not a member maybe you can read the Q&A?

RE:RE:Even if you're not a member maybe you can read the Q&A?Not sure if you can read the Q & A if you are not a member, the live Q&A  with Zeesha 

Saeed is still on, ther are some many Q since 11 am.

Here is few Q,
Mark Roberts Good monring...

1. How does FSD plan to get to Nasdaq and what's the timeline?
2. What are the top three focuses for the next 6-12 months?
3. Are we on schedule for Phase 1 completion?
Manage
 
Like
Reply1h
Zeeshan Saeed We have a shareholders meeting coming up on 22 January I believe. Once the NASDAQ listing is approved by the majority of the shareholders we will start the process of getting listed. It should take 6 - 8 weeks after that
2
Manage
 
Like
Reply59m
Zeeshan Saeed One thing I would like to clear is that NASDAQ listing is not dependent on the acquisition of Therapix

Zeeshan Saeed Retail license is in evitable. We had a delay because of some results on the last crop, but the latest crop has gone for testing and we are confident that it will pass all tests. Once we get the results we will send it to Health Canada. Please keep your finger crossed

Zeeshan Saeed We know that reverse splits are never good for any company and mostly results in a decrease in share price. Like i said we will never vote on a reverse split unless its backed by big institutional money and we feel is only going to benefit shareholders

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities